Veterinary Intravenous (IV) Solutions Global Market Report 2026
상품코드:1938733
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
수의용 정맥내(IV) 수액 시장의 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 16억 2,000만 달러에서 2026년에는 17억 5,000만 달러로, CAGR 8.1%로 확대할 전망입니다. 지난 수년간 성장 요인으로는 동물의 탈수증상 및 전해질 균형 장애 증가, 반려동물 수 증가, 동물병원 및 진료소 증가, 기존 정맥주사제 도입, 수의학 수액요법 기술 발전 등을 꼽을 수 있습니다.
수의용 정맥내(IV) 수액 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 23억 6,000만 달러에 달하며, CAGR은 7.7%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 고급 등장성 및 콜로이드 용액에 대한 수요 증가, 수의학에서 비경구 영양법 채택 증가, 집중 치료를 위한 특수 IV 용액 개발, 수액 요법의 장점에 대한 인식 증가, 수의학 응급 및 집중 치료 서비스 확대 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 첨단 등장성 및 전해질 균형 용액 개발, 합성 및 천연 콜로이드의 사용 증가, 반려동물 및 생산 동물용 비경구 영양 용액의 성장, 프리믹스 및 즉시 사용 가능한 정맥내 용액의 채택 확대, 수의학에서 집중 치료 및 응급 수액 요법의 확대 등을 들 수 있습니다.
다양한 동물 질병의 발생률 증가는 향후 수의용 정맥주사(IV) 솔루션 시장의 성장을 가속할 것으로 예측됩니다. 동물 질병이란 동물의 건강과 기능을 손상시키는 상태나 장애를 말하며, 일반적인 예로는 탄저병, 렙토스피라증, 광견병,개 디스템퍼, 필라리아증 등을 들 수 있습니다. 질병 발생률 증가는 집약적 축산 방식, 야생동물 침입, 항생제 내성 등의 요인에 의해 촉진되고 있습니다. 수의용 정맥주사는 위장염, 중증 감염 등 탈수 증상을 유발하는 질병에 걸린 동물에게 최적의 수분 공급을 보장하고 전반적인 건강 상태를 지원함으로써 중요한 역할을 합니다. 예를 들어 프랑스에 본부를 둔 정부간 동물보건기구인 세계동물보건기구(WOAH)에 따르면 2025년 5월 현재 포유류 조류 인플루엔자 발생 건수는 2023년에 비해 2배 이상 증가하여 55개국에서 1,022건이 발생했다고 보고했습니다. 이는 2023년 459건에서 크게 증가한 것으로, 여러 종의 질병 발생률이 크게 증가한 것을 반영합니다. 따라서 동물 질병의 확산이 수의용 정맥주사제 시장의 성장을 촉진하고 있습니다.
동물 건강 제품에 대한 지출 증가는 수의학 정맥주사 시장의 성장을 가속할 것으로 예측됩니다. 동물용 건강 제품에는 동물의 건강 유지 및 개선을 목적으로 하는 의약품, 보충제, 치료법 등이 포함됩니다. 이러한 제품에 대한 지출 증가는 반려동물 인구 증가, 동물 건강에 대한 인식 개선, 수의학 발전, 질병 예방 및 치료 개선에 대한 요구 등의 요인에 의해 촉진되고 있습니다. 수의용 IV 솔루션은 긴급한 의료 수요에 대응하고, 동물 의료의 질을 향상시킴으로써 이러한 추세에 기여하고 있습니다. 예를 들어 2024년 3월 에스토니아 공화국 의약품청은 2023년 동물용 의약품 시장 규모가 6.9% 성장하여 2022년 1,921만 달러(1,740만 유로)에서 2,054만 달러(1,860만 유로)에 달할 것이라고 보고했습니다. 동물용 의약품에 대한 지출 증가가 수의학용 점적투여액 시장의 성장을 촉진하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Veterinary intravenous (IV) solutions are sterile fluids administered directly into an animal's bloodstream through a vein, usually via an IV catheter. These solutions are used in veterinary care to treat dehydration and electrolyte imbalances, deliver medications, or provide essential nutrients. They are crucial for maintaining or restoring fluid and electrolyte balance in animals, particularly during illness, surgery, or trauma.
The main types of veterinary intravenous (IV) solutions include isotonic crystalloids, dextrose solutions, synthetic colloids, natural colloids, and parenteral nutrition. Isotonic crystalloids are IV fluids with a solute concentration equal to that of the blood, helping to maintain fluid balance. These solutions are applicable to various animal types, including companion animals and production animals. They are used by different end-users such as veterinary hospitals and clinics, research institutes, and other related entities.
Tariffs have impacted the veterinary intravenous (IV) solutions market by increasing the cost of imported IV fluids, colloids, and parenteral nutrition components, affecting pricing and availability for veterinary hospitals and clinics. Segments such as isotonic crystalloids, synthetic colloids, and parenteral nutrition are most affected, particularly in regions like North America and Europe dependent on imports. However, tariffs have also encouraged local manufacturing and development of cost-effective IV solutions, creating opportunities for domestic producers and enhancing regional supply resilience.
The veterinary intravenous (iv) solutions market research report is one of a series of new reports from The Business Research Company that provides veterinary intravenous (iv) solutions market statistics, including veterinary intravenous (iv) solutions industry global market size, regional shares, competitors with a veterinary intravenous (iv) solutions market share, detailed veterinary intravenous (iv) solutions market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary intravenous (iv) solutions industry. This veterinary intravenous (iv) solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The veterinary intravenous (iv) solutions market size has grown strongly in recent years. It will grow from $1.62 billion in 2025 to $1.75 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising prevalence of dehydration and electrolyte imbalances in animals, growth in companion animal population, increasing number of veterinary hospitals and clinics, adoption of conventional iv solutions, technological advancements in veterinary fluid therapy.
The veterinary intravenous (iv) solutions market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing demand for advanced isotonic and colloid solutions, increasing adoption of parenteral nutrition in veterinary care, development of specialized iv solutions for critical care, rising awareness of fluid therapy benefits, expansion of veterinary emergency and critical care services. Major trends in the forecast period include development of advanced isotonic and balanced electrolyte solutions, increased use of synthetic and natural colloids, growth in parenteral nutrition solutions for companion and production animals, adoption of pre-mixed and ready-to-use iv solutions, expansion of veterinary critical care and emergency fluid therapy.
The rising prevalence of various animal diseases is expected to drive the growth of the veterinary intravenous (IV) solutions market going forward. Animal diseases include conditions or disorders that impair the health and functioning of animals, with common examples being anthrax, leptospirosis, rabies, canine distemper, heartworm disease, and more. The increase in disease prevalence is driven by factors such as intensive farming practices, wildlife encroachment, and antibiotic resistance. Veterinary intravenous solutions play a crucial role in rehydrating animals affected by dehydration-inducing diseases, such as gastroenteritis or severe infections, by ensuring optimal hydration and supporting overall health outcomes. For example, in May 2025, according to the World Organisation for Animal Health (WOAH), a France-based intergovernmental animal health body, outbreaks of avian influenza in mammals more than doubled compared with 2023, with 1,022 reported outbreaks across 55 countries compared to 459 outbreaks in 2023, reflecting a significant rise in disease prevalence across multiple species. Therefore, the increasing prevalence of animal diseases is driving the growth of the veterinary intravenous (IV) solutions market.
Rising expenditure on animal health products is also expected to propel the growth of the veterinary intravenous (IV) solutions market. Animal health products include medications, supplements, and treatments aimed at maintaining or improving animal health. The rise in spending on these products is driven by factors such as increased pet ownership, greater awareness of animal health, advancements in veterinary care, and the need for improved disease prevention and treatment. Veterinary IV solutions contribute to this trend by addressing urgent medical needs and enhancing veterinary care. For example, the Republic of Estonia Agency of Medicines reported in March 2024 that the veterinary medicinal products market grew by 6.9% in 2023, reaching $20.54 million (18.6 million euros), up from $19.21 million (17.40 million euros) in 2022. This increase in spending on animal health products is driving the growth of the veterinary IV solutions market.
Leading companies in the veterinary IV solutions market are focusing on developing advanced products, such as fluoroquinolone antibiotics, to enhance efficacy and safety. Fluoroquinolones are a potent class of antibiotics used in both human and veterinary medicine to treat a variety of bacterial infections, with careful management to prevent resistance and side effects. For example, in April 2024, Elanco, a US-based pharmaceutical company, introduced Pradalex, a pradofloxacin injection solution approved by the US Food and Drug Administration (FDA). This 3rd generation fluoroquinolone is approved for treating swine respiratory disease (SRD) caused by several pathogens, including Bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. The drug's label advises that it should be used only after other non-fluoroquinolone treatment options have been considered.
Major companies operating in the veterinary intravenous (iv) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Sante Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd
North America was the largest region in the veterinary intravenous (IV) solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (iv) solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the veterinary intravenous (iv) solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The veterinary intravenous (IV) solutions market consists of sales of hypertonic solutions, isotonic solutions, and hypertonic solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Intravenous (IV) Solutions Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses veterinary intravenous (iv) solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for veterinary intravenous (iv) solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary intravenous (iv) solutions market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
2) By Animal Type: Companion Animals; Production Animals
3) By End-User: Veterinary Hospitals And Clinics; Research Institutes; Other End-Users
Subsegments:
1) By Isotonic Crystalloids: Normal Saline (0.9% NaCl); Lactated Ringer's Solution; Dextrose In Water (D5W); Ringer's Solution; Balanced Electrolyte Solutions
2) By Dextrose Solutions: Dextrose 5% In Water (D5W); Dextrose 10% In Water (D10W); Dextrose 20% In Water (D20W); Dextrose 50% In Water (D50W)
3) By Synthetic Colloids: Hydroxyethyl Starch (HES); Dextran; Gelatins
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
4.2. Major Trends
4.2.1 Development Of Advanced Isotonic And Balanced Electrolyte Solutions
4.2.2 Increased Use Of Synthetic And Natural Colloids
4.2.3 Growth In Parenteral Nutrition Solutions For Companion And Production Animals
4.2.4 Adoption Of Pre-Mixed And Ready-To-Use Iv Solutions
4.2.5 Expansion Of Veterinary Critical Care And Emergency Fluid Therapy
5. Veterinary Intravenous (IV) Solutions Market Analysis Of End Use Industries
5.1 Veterinary Hospitals And Clinics
5.2 Research Institutes
5.3 Animal Emergency And Critical Care Centers
5.4 Veterinary Specialty Clinics
5.5 Pharmaceutical And Animal Health Companies
6. Veterinary Intravenous (IV) Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Veterinary Intravenous (IV) Solutions Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Veterinary Intravenous (IV) Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Veterinary Intravenous (IV) Solutions Market Size, Comparisons And Growth Rate Analysis
7.3. Global Veterinary Intravenous (IV) Solutions Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Veterinary Intravenous (IV) Solutions Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Veterinary Intravenous (IV) Solutions Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Veterinary Intravenous (IV) Solutions Market
12.1. China Veterinary Intravenous (IV) Solutions Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Veterinary Intravenous (IV) Solutions Market
13.1. India Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Veterinary Intravenous (IV) Solutions Market
14.1. Japan Veterinary Intravenous (IV) Solutions Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Veterinary Intravenous (IV) Solutions Market
15.1. Australia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Veterinary Intravenous (IV) Solutions Market
16.1. Indonesia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Veterinary Intravenous (IV) Solutions Market
17.1. South Korea Veterinary Intravenous (IV) Solutions Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Veterinary Intravenous (IV) Solutions Market
19.1. South East Asia Veterinary Intravenous (IV) Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Veterinary Intravenous (IV) Solutions Market
20.1. Western Europe Veterinary Intravenous (IV) Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Veterinary Intravenous (IV) Solutions Market
21.1. UK Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Veterinary Intravenous (IV) Solutions Market
23.1. France Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25.1. Spain Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Veterinary Intravenous (IV) Solutions Market
26.1. Eastern Europe Veterinary Intravenous (IV) Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Veterinary Intravenous (IV) Solutions Market
27.1. Russia Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Veterinary Intravenous (IV) Solutions Market
28.1. North America Veterinary Intravenous (IV) Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Veterinary Intravenous (IV) Solutions Market
29.1. USA Veterinary Intravenous (IV) Solutions Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Veterinary Intravenous (IV) Solutions Market
31.1. South America Veterinary Intravenous (IV) Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Veterinary Intravenous (IV) Solutions Market
32.1. Brazil Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Veterinary Intravenous (IV) Solutions Market
33.1. Middle East Veterinary Intravenous (IV) Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Veterinary Intravenous (IV) Solutions Market
34.1. Africa Veterinary Intravenous (IV) Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Veterinary Intravenous (IV) Solutions Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Veterinary Intravenous (IV) Solutions Market Regulatory and Investment Landscape
36. Veterinary Intravenous (IV) Solutions Market Competitive Landscape And Company Profiles
